ACADL and hepatocellular carcinoma: Zhao et al. found that long-chain acyl-coA dehydrogenase (ACADL, a mitochondrial enzyme that catalyzes fatty acid oxidation) is frequently down-regulated in HCC, leading to poor clinical outcomes in HCC patients.